Want to see KPTI full AI Analyst Report?
KPTI Analyst Ratings
Moderate Buy
3 Buy
3 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
KPTI Stock 12 Month Forecast
Average Price Target
$7.20
▼(-2.83% Downside)
| Highest Price Target$11.00 | Average Price Target$7.20 | Lowest Price Target$3.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
H.C. Wainwright
$13→$3
Hold
-59.51%
Downside
Downgraded
07/31/26
RBC Capital
$16→$8
Buy
7.96%
Upside
Reiterated
07/31/26
Jefferies
$14→$11
Buy
48.45%
Upside
Reiterated
07/31/26
Piper Sandler
$16→$7
Buy
-5.53%
Downside
Reiterated
07/31/26
Robert W. Baird
―
Hold
―
Downgraded
07/31/26
Rodman & Renshaw
$28
Buy
277.87%
Upside
Initiated
03/09/26
Cantor Fitzgerald
―
Buy
―
Reiterated
03/06/26
Barclays
$10
Buy
34.95%
Upside
Reiterated
11/04/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
H.C. Wainwright
$13→$3
Hold
-59.51%
Downside
Downgraded
07/31/26
RBC Capital
$16→$8
Buy
7.96%
Upside
Reiterated
07/31/26
Jefferies
$14→$11
Buy
48.45%
Upside
Reiterated
07/31/26
Piper Sandler
$16→$7
Buy
-5.53%
Downside
Reiterated
07/31/26
Robert W. Baird
―
Hold
―
Downgraded
07/31/26
Rodman & Renshaw
$28
Buy
277.87%
Upside
Initiated
03/09/26
Cantor Fitzgerald
―
Buy
―
Reiterated
03/06/26
Barclays
$10
Buy
34.95%
Upside
Reiterated
11/04/25
Best Analysts Covering Karyopharm Therapeutics
3 Months
Success Rate
7/19 ratings generated profit
Average Return
-12.28%
Copying Peter Lawson's trades and holding each position for 3 Months would result in 36.84% of your transactions generating a profit, with an average return of -12.28% per trade.
1 Year
Success Rate
5/31 ratings generated profit
Average Return
-41.22%
Copying Brian Abrahams's trades and holding each position for 1 Year would result in 16.13% of your transactions generating a profit, with an average return of -41.22% per trade.
2 Years
Success Rate
0/19 ratings generated profit
Average Return
-70.00%
Copying Peter Lawson's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -70.00% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
KPTI Analyst Recommendation Trends
Rating
Apr 26
May 26
Jun 26
Jul 26
Aug 26
Strong Buy
9
8
3
5
4
Buy
4
2
2
3
2
Hold
0
1
1
3
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
13
11
6
11
8
Each month's total comprises the sum of three months' worth of ratings.
KPTI Financial Forecast
KPTI Stock Forecast FAQ
What is KPTI’s average 12-month price target, according to analysts?
Based on analyst ratings, Karyopharm Therapeutics INC’s 12-month average price target is 7.20.
What is KPTI’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for KPTI, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is KPTI a Buy, Sell or Hold?
Karyopharm Therapeutics INC has a consensus rating of Moderate Buy which is based on 3 buy ratings, 3 hold ratings and 0 sell ratings.
What is Karyopharm Therapeutics INC’s price target?
The average price target for Karyopharm Therapeutics INC is 7.20. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $11.00 ,the lowest forecast is $3.00. The average price target represents -2.83% Decrease from the current price of $7.41.
The highest analyst price target is $11.00 ,the lowest forecast is $3.00. The average price target represents -2.83% Decrease from the current price of $7.41.
What do analysts say about Karyopharm Therapeutics INC?
Karyopharm Therapeutics INC’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 6 Wall Streets Analysts.
How can I buy shares of KPTI?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.